Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEDIZINAL-Cannabisblüten Typ 1 DEMECAN
- Development stage
- Unknown
- Lead developer
- DEMECAN
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation
01
Overview
MEDIZINAL-Cannabisblüten Typ 1 DEMECAN is a medical cannabis flower product developed and manufactured in Germany by DEMECAN. It is derived from the Bubba Kush cultivar (an Indica-dominant strain) and contains approximately 21% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). The product is cultivated under strict pharmaceutical conditions (GMP standards) and is indicated for the treatment of severe, treatment-resistant conditions such as chronic pain, spasticity associated with multiple sclerosis, sleep disorders, anxiety, depression, and appetite loss. Its therapeutic effects are primarily mediated by THC acting as a partial agonist at cannabinoid CB1 and CB2 receptors, which modulates neurotransmitter release and pain signaling pathways.
- Brand names
- MEDIZINAL-Cannabisblüten Typ 1 DEMECAN
- Other names
- Cannabisblüten Typ 1 DEMECANDemecan Typ 1Demecan Typ 1 BKDemecan Typ 1 Bubba Kush
02
Targets
CNR1 (Cannabinoid receptor 1)PPAR (PPAR family)
Beyond the preview
Go deeper on MEDIZINAL-Cannabisblüten Typ 1 DEMECAN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEDIZINAL-Cannabisblüten Typ 1 DEMECAN.